These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice. Lyu B, Wang W, Ji XY, Ritter JK, Li N. BMC Nephrol; 2020 May 11; 21(1):173. PubMed ID: 32393187 [Abstract] [Full Text] [Related]
4. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Chan CT, Moore JP, Budzyn K, Guida E, Diep H, Vinh A, Jones ES, Widdop RE, Armitage JA, Sakkal S, Ricardo SD, Sobey CG, Drummond GR. Hypertension; 2012 Nov 11; 60(5):1207-12. PubMed ID: 23033370 [Abstract] [Full Text] [Related]
5. Role of gp91phox-containing NADPH oxidase in the deoxycorticosterone acetate-salt-induced hypertension. Fujii A, Nakano D, Katsuragi M, Ohkita M, Takaoka M, Ohno Y, Matsumura Y. Eur J Pharmacol; 2006 Dec 15; 552(1-3):131-4. PubMed ID: 17064681 [Abstract] [Full Text] [Related]
11. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats. Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B. Life Sci; 2016 Apr 15; 151():288-299. PubMed ID: 26969765 [Abstract] [Full Text] [Related]
12. TMEM16A and myocardin form a positive feedback loop that is disrupted by KLF5 during Ang II-induced vascular remodeling. Zhang XH, Zheng B, Yang Z, He M, Yue LY, Zhang RN, Zhang M, Zhang W, Zhang X, Wen JK. Hypertension; 2015 Aug 15; 66(2):412-21. PubMed ID: 26077572 [Abstract] [Full Text] [Related]
13. mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO/cGMP. Jia Z, Aoyagi T, Yang T. Hypertension; 2010 Feb 15; 55(2):539-46. PubMed ID: 20065149 [Abstract] [Full Text] [Related]
14. Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension. Toque HA, Nunes KP, Rojas M, Bhatta A, Yao L, Xu Z, Romero MJ, Webb RC, Caldwell RB, Caldwell RW. Front Immunol; 2013 Feb 15; 4():219. PubMed ID: 23908657 [Abstract] [Full Text] [Related]
15. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. O'Brien D, Chunduri P, Iyer A, Brown L. Basic Clin Pharmacol Toxicol; 2010 Apr 15; 106(4):296-301. PubMed ID: 20041879 [Abstract] [Full Text] [Related]
16. Interactions of PPAR α and GLUT4 in DOCA/salt-induced renal injury in mice. Ighodaro I, Eric OK, Adebayo O. Niger J Physiol Sci; 2013 Dec 20; 28(2):127-33. PubMed ID: 24937386 [Abstract] [Full Text] [Related]
19. Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice. Sun GQ, Li YB, Du B, Meng Y. Clin Exp Hypertens; 2015 Dec 20; 37(8):616-21. PubMed ID: 26114354 [Abstract] [Full Text] [Related]
20. Collecting duct-specific knockout of sphingosine-1-phosphate receptor 1 aggravates DOCA-salt hypertension in mice. Hu G, Zhu Q, Wang W, Xie D, Chen C, Li PL, Ritter JK, Li N. J Hypertens; 2021 Aug 01; 39(8):1559-1566. PubMed ID: 33534341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]